Applying Lucentis for the treatment of retinopathy of prematurity
Purpose: to evaluate the efficacy of Lucentis for the treatment of retinopathy of prematurity (ROP). Material and methods. 51 infants (102 eyes) with the gestational age between 24 and 33 weeks were given intravitreal injections of Lucentis, All patients selected had ROP stages I+, II+, III or III+...
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Real Time Ltd
2022-12-01
|
Series: | Российский офтальмологический журнал |
Subjects: | |
Online Access: | https://roj.igb.ru/jour/article/view/1096 |